Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activity of Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment

E. Lefebvre, M. Gottwald, K. Lasseter, W. Chang, M. Willett, P. F. Smith, A. Somasunderam, N. S. Utay

Research output: Contribution to journalArticlepeer-review

36 Scopus citations
Original languageEnglish (US)
Pages (from-to)139-148
Number of pages10
JournalClinical and translational science
Volume9
Issue number3
DOIs
StatePublished - Jun 1 2016
Externally publishedYes

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint

Dive into the research topics of 'Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activity of Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment'. Together they form a unique fingerprint.

Cite this